Iron metabolism and anemia may play an important role in multiple organ dysfunction during the ongoing COVID-19 pandemic. Patients with iron deficiency are more susceptible to coronavirus. Hence, companies in the iron deficiency anemia treatment market have increased their output capacities to avoid supply shocks for medications in pharmacies and hospitals.
They are increasing efforts to identify risk factors that can help to optimize hospital resources and create an awareness about public health recommendations. The potential association between anemia and coronavirus has compelled pharmaceutical companies to boost their output capacities of drugs and other medications. This is likely to drive the iron deficiency anemia treatment market.
The iron deficiency anemia treatment market is projected to reach US$ 22.7 Bn by 2030. Anemia is associated with the loss of billions of dollars annually in terms of productivity of working women residing in developing economies. Hence, pharmaceutical companies are conducting iron supplementation programs in order to eradicate the medical condition among women doing manual labor jobs.
However, low adherence to supplementation, hidden symptoms, and lack of program monitoring are affecting market growth. Hence, companies are increasing awareness about frequent visits to clinics, adequate dosing of supplements, and prioritizing monitoring of programs to boost market growth.
Pharmaceutical companies in the iron deficiency anemia treatment market are tapping into incremental opportunities in India, as nearly half of the women population in India is anemic. This explains why the iron deficiency anemia treatment market is predicted to register a robust CAGR of 8.7% during the assessment period. Iron-folic acid supplements are emerging as efficacious medication in the eradication of anemia in India.
Apart from iron supplements, manufacturers in the iron deficiency anemia treatment market are making advancements in intravenous (IV) infusion treatments for patients with chronic illnesses. New possibilities for iron supplementation with the help of antiplatelet drugs, anticoagulants, and anti-inflammatory drugs are projected to bolster market growth.
Manufacturers are developing improved formulations in drugs involving ferrous sulfate, gluconate, and iron fumarate, owing to their better bioavailability than other compounds. They are innovating in drugs containing divalent iron salts, since these drugs are relatively cheap for purchase in pharmacies and drug stores.
Analysts’ Viewpoint
Since the coronavirus pandemic has caused a significant impact on healthcare facilities, pharmaceutical companies have amped up their production targets to tide over uncertainties in demand and supply. The World Health Organization (WHO) has encouraged technological innovations such as conducting webinars to facilitate anemia prevention programs. However, there is a need for robust healthcare infrastructure in developing economies such as India, where a significant percentage of women population are anemic.
Hence, pharmaceutical companies in the iron deficiency anemia treatment market should invest in building the healthcare infrastructure of India and prioritize monitoring of anemia eradication programs. Companies should increase efforts to enable high adherence to dosages and innovate with divalent iron salts and ferrous sulfate to increase availability of efficacious drugs.
Iron deficiency anemia treatment market is projected to reach US$ 22.7 Bn by 2030
Iron deficiency anemia treatment market is predicted to register a robust CAGR of 8.7% from 2020 to 2030
Iron deficiency anemia treatment market is driven by rise in prevalence of chronic kidney diseases
The ferrous sulfate segment dominated the global iron deficiency anemia treatment market, and the trend is projected to continue during the forecast period
Key players in the global iron deficiency anemia treatment market are AdvaCare Pharma, Akorn, Sun Pharmaceutical Industries Ltd., Akebia Therapeutics, Inc., Rockwell Medical, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Iron Deficiency Anemia Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Source Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Iron Deficiency Anemia Treatment Market Analysis and Forecast, 2018–2030
5. Key Insights
5.1. Iron Deficiency Anemia Treatment Disease Prevalence: By Major Regions/Countries
5.2. Overview: Regulatory Scenario in Iron Deficiency Anemia Treatment Treatment Market, by Major Countries/Regions, 2019
5.3. Pipeline Analysis
5.4. COVID-19 Impact Analysis
6. Global Iron Deficiency Anemia Treatment Market Analysis and Forecast, by Drug Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
6.3.1. Ferrous Sulfate
6.3.2. Ferrous Gluconate
6.3.3. Ferrous Fumerate
6.3.4. Ferric Hydroxide
6.3.5. Sodium Ferric Gluconate
6.3.6. Iron Carbohydrates
6.3.7. Others
6.4. Global Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Drug Type
7. Global Iron Deficiency Anemia Treatment Market Analysis and Forecast, by Dosage Form
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
7.3.1. Tablets
7.3.2. Capsules
7.3.3. Liquid
7.4. Global Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Dosage Form
8. Global Iron Deficiency Anemia Treatment Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Global Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Distribution Channel
9. Global Iron Deficiency Anemia Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Country/Region
10. North America Iron Deficiency Anemia Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
10.2.1. Ferrous Sulfate
10.2.2. Ferrous Gluconate
10.2.3. Ferrous Fumerate
10.2.4. Ferric Hydroxide
10.2.5. Sodium Ferric Gluconate
10.2.6. Iron Carbohydrates
10.2.7. Others
10.3. North America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
10.3.1. Tablets
10.3.2. Capsules
10.3.3. Liquid
10.4. North America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. North America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Iron Deficiency Anemia Treatment Market Attractiveness Analysis
10.6.1. By Drug Type
10.6.2. By Dosage Form
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Iron Deficiency Anemia Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
11.2.1. Ferrous Sulfate
11.2.2. Ferrous Gluconate
11.2.3. Ferrous Fumerate
11.2.4. Ferric Hydroxide
11.2.5. Sodium Ferric Gluconate
11.2.6. Iron Carbohydrates
11.2.7. Others
11.3. Europe Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
11.3.1. Tablets
11.3.2. Capsules
11.3.3. Liquid
11.4. Europe Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Europe Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Iron Deficiency Anemia Treatment Market Attractiveness Analysis
11.6.1. By Drug Type
11.6.2. By Dosage Form
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Iron Deficiency Anemia Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
12.2.1. Ferrous Sulfate
12.2.2. Ferrous Gluconate
12.2.3. Ferrous Fumerate
12.2.4. Ferric Hydroxide
12.2.5. Sodium Ferric Gluconate
12.2.6. Iron Carbohydrates
12.2.7. Others
12.3. Asia Pacific Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
12.3.1. Tablets
12.3.2. Capsules
12.3.3. Liquid
12.4. Asia Pacific Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Asia Pacific Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Iron Deficiency Anemia Treatment Market Attractiveness Analysis
12.6.1. By Drug Type
12.6.2. By Dosage Form
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Iron Deficiency Anemia Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
13.2.1. Ferrous Sulfate
13.2.2. Ferrous Gluconate
13.2.3. Ferrous Fumerate
13.2.4. Ferric Hydroxide
13.2.5. Sodium Ferric Gluconate
13.2.6. Iron Carbohydrates
13.2.7. Others
13.3. Latin America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
13.3.1. Tablets
13.3.2. Capsules
13.3.3. Liquid
13.4. Latin America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Latin America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Iron Deficiency Anemia Treatment Market Attractiveness Analysis
13.6.1. By Drug Type
13.6.2. By Dosage Form
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Iron Deficiency Anemia Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
14.2.1. Ferrous Sulfate
14.2.2. Ferrous Gluconate
14.2.3. Ferrous Fumerate
14.2.4. Ferric Hydroxide
14.2.5. Sodium Ferric Gluconate
14.2.6. Iron Carbohydrates
14.2.7. Others
14.3. Middle East & Africa Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
14.3.1. Tablets
14.3.2. Capsules
14.3.3. Liquid
14.4. Middle East & Africa Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Middle East & Africa Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Iron Deficiency Anemia Treatment Market Attractiveness Analysis
14.6.1. By Drug Type
14.6.2. By Dosage Form
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Company Profiles
15.1.1. AdvaCare Pharma
15.1.1.1. Company Overview
15.1.1.2. Company Financials
15.1.1.3. Growth Strategies
15.1.1.4. SWOT Analysis
15.1.2. Akorn
15.1.2.1. Company Overview
15.1.2.2. Company Financials
15.1.2.3. Growth Strategies
15.1.2.4. SWOT Analysis
15.1.3. Sun Pharmaceutical Industries Ltd.
15.1.3.1. Company Overview
15.1.3.2. Growth Strategies
15.1.3.3. SWOT Analysis
15.1.4. Akebia Therapeutics, Inc.
15.1.4.1. Company Overview
15.1.4.2. Growth Strategies
15.1.4.3. SWOT Analysis
15.1.5. Rockwell Medical, Inc.
15.1.5.1. Company Overview
15.1.5.2. Growth Strategies
15.1.5.3. SWOT Analysis
15.1.6. Vifor Pharma Management Ltd.
15.1.6.1. Company Overview
15.1.6.2. Company Financials
15.1.6.3. Growth Strategies
15.1.6.4. SWOT Analysis
15.1.7. SHIELD THERAPEUTICS
15.1.7.1. Company Overview
15.1.7.2. Company Financials
15.1.7.3. Growth Strategies
15.1.7.4. SWOT Analysis
15.1.8. AMAG Pharmaceuticals
15.1.8.1. Company Overview
15.1.8.2. Company Financials
15.1.8.3. Growth Strategies
15.1.8.4. SWOT Analysis
15.1.9. PHARMACOSMOS A/S
15.1.9.1. Company Overview
15.1.9.2. Company Financials
15.1.9.3. Growth Strategies
15.1.9.4. SWOT Analysis
List of Table
Table 01: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 02: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 03: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 04: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 05: North America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 06: North America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 07: North America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 08: North America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 09: Europe Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 10: Europe Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 11: Europe Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 12: Europe Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 13: Asia Pacific Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Asia Pacific Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 15: Asia Pacific Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 16: Asia Pacific Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 17: Latin America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18: Latin America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 19: Latin America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 20: Latin America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 21: Middle East & Africa Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 22: Middle East & Africa Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030
Table 23: Middle East & Africa Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030
Table 24: Middle East & Africa Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
List of Figure
Figure 01: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Iron Deficiency Anemia Treatment Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 03: Global Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Drug Type, 2020–2030
Figure 04: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Ferrous Sulfate, 2018–2030
Figure 05: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Ferrous Gluconate, 2018–2030
Figure 06: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Ferrous Fumerate, 2018–2030
Figure 07: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Ferric Hydroxide, 2018–2030
Figure 08: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Sodium Ferric Gluconate, 2018–2030
Figure 09: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Iron Carbohydrates, 2018–2030
Figure 10: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Others, 2018–2030
Figure 11: Global Iron Deficiency Anemia Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 12: Global Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 13: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Tablets, 2018–2030
Figure 14: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Capsules, 2018–2030
Figure 15: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Liquid, 2018–2030
Figure 16: Global Iron Deficiency Anemia Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 17: Global Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 18: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Hospital Pharmacies, 2018–2030
Figure 19: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Retail Pharmacies, 2018–2030
Figure 20: Global Iron Deficiency Anemia Treatment Market Value (US$ Mn), by Online Pharmacies, 2018–2030
Figure 21: Global Iron Deficiency Anemia Treatment Market Value Share Analysis, by Region, 2019 and 2030
Figure 22: Global Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Region, 2020–2030
Figure 23: North America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 24: North America Iron Deficiency Anemia Treatment Market Value Share Analysis, by Country, 2019 and 2030
Figure 25: North America Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Country, 2020–2030
Figure 26: North America Iron Deficiency Anemia Treatment Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 27: North America Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Drug Type, 2020–2030
Figure 28: North America Iron Deficiency Anemia Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 29: North America Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 30: North America Iron Deficiency Anemia Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 31: North America Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 32: Europe Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 33: Europe Iron Deficiency Anemia Treatment Market Value Share Analysis, by Country/Sub-region, 2019–2030
Figure 34: Europe Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 35: Europe Iron Deficiency Anemia Treatment Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 36: Europe Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Drug Type, 2020–2030
Figure 37: Europe Iron Deficiency Anemia Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 38: Europe Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 39: Europe Iron Deficiency Anemia Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 40: Europe Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 41: Asia Pacific Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 42: Asia Pacific Iron Deficiency Anemia Treatment Market Value Share Analysis, by Country/Sub-region, 2019–2030
Figure 43: Asia Pacific Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 44: Asia Pacific Iron Deficiency Anemia Treatment Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 45: Asia Pacific Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Drug Type, 2020–2030
Figure 46: Asia Pacific Iron Deficiency Anemia Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 47: Asia Pacific Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 48: Asia Pacific Iron Deficiency Anemia Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 49: Asia Pacific Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 50: Latin America Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 51: Latin America Iron Deficiency Anemia Treatment Market Value Share Analysis, by Country/Sub-region, 2019–2030
Figure 52: Latin America Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 53: Latin America Iron Deficiency Anemia Treatment Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 54: Latin America Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Drug Type, 2020–2030
Figure 55: Latin America Iron Deficiency Anemia Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 56: Latin America Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 57: Latin America Iron Deficiency Anemia Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 58: Latin America Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 59: Middle East & Africa Iron Deficiency Anemia Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 60: Middle East & Africa Iron Deficiency Anemia Treatment Market Value Share Analysis, by Country/Sub-region, 2019–2030
Figure 61: Middle East & Africa Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 62: Middle East & Africa Iron Deficiency Anemia Treatment Market Value Share Analysis, by Drug Type, 2019 and 2030
Figure 63: Middle East & Africa Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Drug Type, 2020–2030
Figure 64: Middle East & Africa Iron Deficiency Anemia Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
Figure 65: Middle East & Africa Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Dosage Form, 2020–2030
Figure 66: Middle East & Africa Iron Deficiency Anemia Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 67: Middle East & Africa Iron Deficiency Anemia Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Iron Deficiency Anemia Treatment Market
